Search results
Found 19846 matches for
We lead multidisciplinary applied research and training to rethink the way health care is delivered in general practice and across the community.
Celebrating International Clinical Trials Day 2021
20 May 2021
Each year, International Clinical Trials Day recognises the people who conduct clinical trials, giving our community a chance to say thank you for everything they do to improve public health. This year our trials unit staff are sharing what makes them proud to be part of Oxford’s Primary Care Clinical Trials Unit.
New study shows potential link between bodyweight and risk of severe COVID-19, especially for younger adults
29 April 2021
The first large study to report the effect of bodyweight on risk of worse outcomes from COVID-19 across the full range of body mass index (BMI) is published today in The Lancet Diabetes and Endocrinology journal.
Foods associated with an increased risk of cardiovascular disease and death in middle-age identified
22 April 2021
Two common dietary patterns identified in British adults, which include high intakes of chocolate and confectionary, may be associated with an increased risk of cardiovascular disease and death in middle-age, according to a study published in the open access journal BMC Medicine by Oxford University researchers.
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
12 April 2021
Inhaled budesonide, a common corticosteroid, is the world's first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants. As of today, the treatment is available in UK primary care on a case-by-case basis.
Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trial
8 April 2021
Could the antiviral favipiravir help transform COVID-19 into an illness that can be successfully treated by general practitioners?
Risk of severe COVID-19 from asthma and other respiratory diseases may be only modestly increased, new analysis suggests
2 April 2021
People with asthma have only a modestly increased risk of developing severe Covid-19 and requiring admission to hospital from the illness, finds an analysis of 8.3 million electronic health care records in England led by University of Oxford researchers.
Five simple steps to effective opportunistic weight loss conversations in family practice
26 March 2021
Five simple communication changes could enable doctors to have more equitable and effective conversations about weight loss, finds new research from the University of Oxford and Loughborough University. With obesity as one of the few modifiable risk factors for developing severe COVID, the findings are especially important during the current pandemic.
NIHR School for Primary Care Research relaunches with new focus to strengthen whole primary care research sector
24 March 2021
Oxford University continues its membership of the national school, while the directorate transfers to Keele University.
Adults living with children faced small increased COVID-related risks during UK’s second wave
19 March 2021
Close monitoring and evaluation as schools reopen crucial to inform ongoing policy
Oxford-led research makes BJGP Open's top ten most read open research articles of 2020
5 March 2021
Three articles, led by Oxford researchers in the department, including three DPhil students, make the top 10 list for the most read open research articles in the BJGP Open for 2020 - including number one.
PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine
3 March 2021
From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.